Almac’s Clinical Technologies unit has formed an exclusive alliance with Greenphire to offer joint services relating to patient payment administration for clinical trials. This new service aims to improve current methods of manual patient payment management and alleviate administrative burden for biopharma companies and CROs.
 
Greenphire has worked with Almac to incorporate its ClinCard System, a patient payment management suite of technologies, with Almac’s IXRS system, an integrated phone and web platform. This offering provides patients with direct and timely compensation via a branded debit card. After patients complete required study-related tasks and responsibilities, their debit card is automatically and immediately credited with the appropriate stipend or reimbursement amount.
 
Jim Murphy, Almac’s president, said, “Our customers are increasingly looking to Almac to help them find ways of improving patient management and compliance during clinical trials. Partnering with Greenphire enhances Almac’s suite of patient-centric services by offering direct-to-patient payments to subjects enrolled in clinical trials. This new joint service allows Almac to more efficiently manage patient payments and tie them closely to key study milestones through our IXRS technology.”
 
Greenphire’s chief executive officer, Sam Whitaker, commented, “Our strategic partnership is groundbreaking. Greenphire’s technology has had a significant impact on driving efficiency to all of the key organizations responsible for executing study operations. Our integrated functionality with Almac not only increases the value to Greenphire’s current ClinCard offering, but also drives clinical operational efficiencies which new clients could never have achieved in the past.”